作者
Davide Serrano,Sara Gandini,Parjhitham Thomas,Katherine D. Crew,Nagi B. Kumar,Lana A. Vornik,J. Jack Lee,Paolo Veronesi,Giuseppe Viale,Aliana Guerrieri‐Gonzaga,Matteo Lazzeroni,Harriet Johansson,Mauro D’Amico,Flavio Guasone,Stefano Spinaci,Bjørn-Erik Bertelsen,Gunnar Mellgren,Isabelle Bedrosian,Diane Weber,Tawana Castile,Eileen Dimond,Brandy M. Heckman-Stoddard,Éva Szabó,Powel H. Brown,Andrea DeCensi,Bernardo Bonanni
摘要
Successful therapeutic cancer prevention requires definition of the minimal effective dose. Aromatase inhibitors decrease breast cancer incidence in high-risk women, but use in prevention and compliance in adjuvant settings are hampered by adverse events.